
AMGN vs ARGX
$AMGN vs $ARGX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AMGN vs ARGX: the quick read
- ·AMGN is the larger company by market cap ($208.49B vs $61.96B).
- ·AMGN has been more active on our scanner (105 vs 36 alerts in 30 days).
- ·ARGX has the smaller float (61.9M vs 537.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 105 and 36 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·AMGN pays a dividend and ARGX does not, which usually means one is being held for income and the other for the move.
- ·AMGN is the one in play today, trading about 3.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AMGN and ARGX on TheDesperateTrader.
- Is AMGN or ARGX the better stock?
- "Better" depends on your goal, and these two are not alike. AMGN is the larger company by market cap ($208.49B vs $61.96B). AMGN has been more active on our scanner (105 vs 36 alerts in 30 days). ARGX has the smaller float (61.9M vs 537.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AMGN and ARGX?
- The differences that matter: they are not in the same business - AMGN is biological products, (no diagnostic substances) and ARGX is biological products, (no diagnostic substances); AMGN is roughly 3x the size of the other by market cap ($208.49B vs $61.96B); they trade at very different share prices ($385.25 vs $990.32); AMGN sits at 65% of its 52-week range against 80% for ARGX; only AMGN pays a dividend; our scanner flagged AMGN 105 times in the last 30 days against 36 for ARGX. Everything above is measured from the latest completed session and SEC filings.
- Which of AMGN and ARGX is more active right now?
- Right now AMGN is at about 3.2x its normal volume and ARGX is at about 0.9x, so AMGN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AMGN or ARGX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AMGN and ARGX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.